Ertapenem Can Be Safely Administered to Patients with Penicillin Allergy
Ertapenem may be administered to patients with a history of penicillin or cephalosporin allergy without prior testing or additional precautions, as cross-reactivity is extremely low (less than 1%). 1
Evidence-Based Recommendation
The 2022 Drug Allergy Practice Parameter from the Journal of Allergy and Clinical Immunology provides clear guidance: carbapenems (including ertapenem) can be given to patients with penicillin or cephalosporin allergy histories without testing, as long as the allergy was not a severe delayed cutaneous or organ-involved reaction 1. This is a conditional recommendation with moderate certainty of evidence.
Key Supporting Data:
- Cross-reactivity rate: Only 0.87% (95% CI: 0.32-2.32%) across 1,127 patients with penicillin allergy 1
- Prospective study: All 211 patients with skin test-confirmed penicillin allergy tolerated carbapenems 1
- IgE-mediated reactions: Among 295 patients with positive penicillin skin tests, only 1 (0.3%) had a potentially IgE-mediated reaction to carbapenem 1
When to Exercise Caution
Contraindications (per FDA label):
- Known hypersensitivity to ertapenem components 2
- Anaphylactic reactions to β-lactams 2
- Severe delayed cutaneous reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) 1
- Organ-involved reactions to penicillins 1
Consider graded challenge in:
- Patients with multiple drug allergies 1
- Significant patient anxiety 1
- History of anaphylaxis to penicillins (though still likely safe) 1
Standard Dosing
Adults 2:
- Treatment: 1 gram IV or IM once daily for up to 14 days (IV) or 7 days (IM)
- Prophylaxis (colorectal surgery): 1 gram single dose given 1 hour pre-operatively
Pediatrics (3 months to 12 years) 2:
- 15 mg/kg IV or IM twice daily (maximum 1 g/day)
Renal adjustment required 2, 3:
- CrCl ≤30 mL/min/1.73 m²: Reduce to 0.5 g daily
- Hemodialysis: 0.5 g daily; if dose given 6 hours before dialysis, give supplemental 150 mg post-dialysis
Clinical Pitfalls to Avoid
Do not routinely avoid carbapenems in penicillin-allergic patients—this practice should be abandoned given the very low cross-reactivity rate 4, 5
Do not mix or co-infuse ertapenem with other medications 2
Do not use diluents containing dextrose 2
Monitor for seizures in patients with CNS disorders or renal impairment 2
Avoid co-administration with valproic acid/divalproex sodium—carbapenems reduce valproic acid levels, increasing seizure risk 2
Practical Implementation
Research confirms safety: A study of 49 patients with confirmed IgE-mediated β-lactam allergy showed 35 of 36 patients tolerated full-dose ertapenem after negative skin testing 4. Another study of 212 consecutive subjects with positive penicillin skin tests found that 211 tolerated carbapenem challenges 5.
The practice of routinely avoiding carbapenems in β-lactam-allergic patients is outdated and should be discontinued 4, 6. The cross-reactivity between penicillins and carbapenems is not based on shared side chains but rather on the β-lactam ring itself, which is structurally different enough in carbapenems to make clinically significant reactions exceedingly rare 7.